The global Interlaminar Device market is expected to grow at a CAGR of 5.6% during the forecast period 2022 – 2027.
Interlaminar device generally refers to the condition defined by the compression of nerve roots and shortening of the spinal canal as a result of numerous pathologic causes, which further leads to symptoms such as pain with a tingling sensation, numbness, and weakness. The cervical, lumbar, or thoracic (rarely) spines may all have spinal stenosis. The development of sophisticated bone grafting products, the rise in spinal illnesses, technological developments in spine surgery, and the growing popularity of minimally invasive spine procedures are just a few of the causes contributing to the interlaminar device's growth. Additionally, major firms throughout the world concentrate on technological developments to increase the effectiveness of interlaminar devices, broaden their market applicability, and support creative growth potential. Furthermore, presenting a unique product to the market allows organizations to gain a competitive advantage and improve product acceptance. Furthermore, the rising incidence of road accidents or traffic injuries worldwide is expected to enhance global market growth in the future. The World Health Organization (WHO) estimates that 1.3 million people worldwide have their lives cut short as a result of a road traffic accident each year. Between 20 and 50 million people experience non-fatal injuries, and many of them become disabled as a result. Additionally, rising rates of diabetes mellitus and serious infections that harm the spinal cord, such as meningitis and spinal epidural abscess, are anticipated to fuel global market expansion in the coming years.
Jan. 5, 2022: NuVasive Receives FDA Clearance for Expanded Indications of Use for Attrax Putty with Company's Thoracolumbar Interbody Portfolio --
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company received U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax® Putty with its comprehensive thoracolumbar interbody portfolio for spine surgery. Attrax Putty is the first synthetic biologic to receive indications for use in interbody fusions of the thoracolumbar spine.
Market is segmented based on the type, applications, companies and regions.
By Type, it is segmented into
By Application, it is segmented into
The market in North America is expected to grow the fastest during the projected period, owing to an increasing number of patients suffering from spinal cord injuries and the region's well-established healthcare infrastructure. High health spending, particularly in the United States, is also anticipated to support market expansion in the area in the next years. The Centers for Medicare & Medicaid Services (CMS) estimate that healthcare spending in the United States would increase by 9.7% in 2020 to reach USD 4.1 trillion. The amount spent on health represented 19.7% of the country's GDP. The European region is poised to observe a dominant demand for interlaminar devices as a result of better healthcare infrastructure, greater awareness, an improving reimbursement picture, and expanding insurance coverage. Other variables that contribute to this trend in Europe include increased senior populations, increasing degenerative spine disease treatment rates, technological advancements in medicine, and a rise in desire for minimally invasive procedures.
The Interlaminar Device Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Interlaminar Device Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
Report Attributes | Report Details |
Forecast Period 2022 to 2027 CAGR | CAGR of 5.6% over the forecast period (2022-2027) |
By Type |
|
By Application |
|
By Companies | NuVasive, Life Spine, Lanx acquired by BioMet, X-Spine, Pioneer Surgical, Spine Frontier, Amedica Corp., Camber Spine Technologies, DePuy Synthes, Implanet, Mazor Robotics, Zimmer Biomet, Xtant Medical, Alphatec Holdings, Inc., Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC |
Regions Covered |
|
Countries Covered |
|
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2022 to 2027 |
Number of Pages | 110 |
Customization Available | Yes, the report can be customized as per your needs |
What is the growth rate of Interlaminar Device Market?
The Interlaminar Device Market is growing at a CAGR of 5.6% over the next 5 years.
Who are the key players in Interlaminar Device Market?
NuVasive, Life Spine, Lanx acquired by BioMet, X-Spine, Pioneer Surgical, Spine Frontier, Amedica Corp., Camber Spine Technologies, DePuy Synthes, Implanet, Mazor Robotics, Zimmer Biomet, Xtant Medical, Alphatec Holdings, Inc., Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC
What are the significant types of Interlaminar Device Market?
Interspinous Distraction Devices, Coflex Device
What are the major end-use applications of Interlaminar Device Market?
Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others
All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
Reach us with your research requirements and we shall provide the optimum solution to suit your needs.
Discounts available for multiple report purchases.